Electronic prescriptions, consumer segmentation, drug prices, and more: Five on Friday for the Week of March 14
Welcome to the latest edition of Cast & Hue’s Five on Friday newsletter. Each Friday, we deliver a quick summary of five items of note associated with the evolving healthcare consumer, strategy and marketing. We hope you find it interesting and useful!
The New York Times
The shift to healthcare IT has mostly revolved around patient records and telemedicine, but there are other areas that are ripe for disruption within the healthcare industry. One of those things has been a long time coming. On March 27th, the state of New York will be mandating that all doctors create their prescriptions electronically rather than writing on prescription pads which are notoriously hard to read. In this article by Sharon Ottoman for the New York Times, you’ll find the reasoning behind the switch, how hospitals are preparing for it, and how it will effect healthcare in the big apple.
With so many changes happening in healthcare over he last few years and a presidential election heavily centered around healthcare policy, many Americans are feeling lost and are having trouble understanding what healthcare options are available to them and how different policies affect them. In a new study by Rice University, they found that a striking percentage of Americans don’t understand even some of the most basic concepts related to healthcare and insurance. In this article by Bruce Jansen for Forbes, we find out the true extent to which people don’t understand healthcare, and how the industry can correct this issue.
Hospitals and Health Networks
Conventional medical practice doesn’t necessarily take their patients behaviors and motivations into consideration when administering care, but according to this article for Hospitals and Health Networks, utilizing consumer segmentation can aid in patient experience and care in a very meaningful way. In this article, you’ll find how some organizations have benefitted by implementing consumer segmentation, and the steps that systems can take to create a consumer segmentation program of their own.
Drug pricing has been in the news quite a bit lately. With the issues surrounding Valeant and the controversy with Turing pharmaceuticals, drug pricing has come under a microscope by the government and the United States public, but are there some drugs that should be priced high? In this opinion piece by Dhruv Khullar, he asks this very question looking to the extended value of each medication for an answer. If a drug provides more benefits aside from simply treating a condition, is it justifiable that it should have a higher price tag? Read on to find out for yourself!
The shift to electronic health records has been quite slow, but is beginning to pick up speed. Recently, New York City’s health department has begun the transition to EHRs for its public hospitals, but this transition has hit somewhat of a snag. Dr. Charles Perry, the former CMIO of Elmhurst Hospital Center and Queens Hospital Center, resigned saying that the transition is being rushed for financial reasons and went on to compare the transition to the Challenger spacecraft disaster. For more information on the resignation as well as insight into the transition to EHRs, make sure to read on!
That is it for this week. We hope you find value in this newsletter and invite you to share your thoughts in the comments section.